RecruitingPHASE1, PHASE2NCT07101640

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Intervention
montelukast 4 mg granule(drug)
Enrollment
28 enrolled
Eligibility
All sexes
Timeline
20262028

Study locations (4)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · University of North Carolina, Chapel Hill · University Medical Center of Southern Nevada · East Carolina University · University of Massachusetts, Worcester · Arkansas Children's Hospital Research Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07101640 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials